{
    "Additional Indicators": [
        {
            "description": "Unfavorable Prognosis",
            "therapy": "NCCN, Consensus, Non-Small Cell Lung Cancer",
            "mutation": "KRASp.G12C Gain-of-function"
        }
    ],
    "Clinical trials": [
        {
            "description": "A Study of VS-6766 v. VS-6766 + Defactinib in Recurrent G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer ",
            "phase": "Phase 2",
            "mutations": [
                "KRAS"
            ]
        },
        {
            "description": "A Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1",
            "phase": "Phase 1/2",
            "mutations": [
                "KRAS",
                "STK11"
            ]
        },
        {
            "description": "First-in-human Study of DRP-104 (Sirpiglenastat) as Single Agent and in Combination With Atezolizumab in Patients With Advanced Solid Tumors. (NCT04471415)",
            "phase": "Phase 1/2",
            "mutations": [
                "NFE2L2",
                "STK11"
            ]
        }
    ],
    "variants of unknown significance": {
        "Somatic": [
            {
                "Gene": "H3.3",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.G35R Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "15.75%"
            },
            {
                "Gene": "SF3B1",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.D781X Nonsense-GOF",
                "VariantAlleleFraction": "2.12%"
            },
            {
                "Gene": "ERBB2",
                "DNA Alteration": "c.1976_1977delinsAG",
                "GeneMutation": "p.T733I Frameshift-GOF",
                "VariantAlleleFraction": "11.53%"
            },
            {
                "Gene": "MUTYH",
                "DNA Alteration": "c.1014G>C",
                "GeneMutation": "p.Q338H Frameshift-GOF",
                "VariantAlleleFraction": "9.8%"
            },
            {
                "Gene": "FGFR4",
                "DNA Alteration": "c.1162G>A",
                "GeneMutation": "p.G388R Nonsense-GOF",
                "VariantAlleleFraction": "7.89%"
            },
            {
                "Gene": "MYOD1",
                "DNA Alteration": "c.365T>G",
                "GeneMutation": "p.L122R Nonsense-LOF",
                "VariantAlleleFraction": "5.49%"
            },
            {
                "Gene": "FOXL2",
                "DNA Alteration": "c.402C>G",
                "GeneMutation": "p.C134W Spliceregionvariant-LOF",
                "VariantAlleleFraction": "4.71%"
            },
            {
                "Gene": "EGFR",
                "DNA Alteration": "c.2375T>A",
                "GeneMutation": "p.S768_V769insVAS Spliceregionvariant-LOF",
                "VariantAlleleFraction": "6.99%"
            },
            {
                "Gene": "RNF43",
                "DNA Alteration": "c.461C>T",
                "GeneMutation": "p.D140E Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "3.16%"
            },
            {
                "Gene": "TLR8",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.N515H Spliceregionvariant-LOF",
                "VariantAlleleFraction": "6.38%"
            },
            {
                "Gene": "CSF3R",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.G751A Nonsense-LOF",
                "VariantAlleleFraction": "5.88%"
            },
            {
                "Gene": "ZEB2",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.H1038R Frameshift-GOF",
                "VariantAlleleFraction": "6.18%"
            }
        ],
        "Germline": []
    }
}